RLMD Relmada Therapeutics, Inc.

Healthcare

$7.04-2.36%ClosedMarket Cap: $516.3M

As of 2026-05-25

Analyst Consensus

Consensus

Buy

Target (Consensus)

$9.00

Target (Median)

$9.00

Target Range

$8.00 - $10.00

Upside from current price: 27.8%

1 Strong Buy4 Buy0 Hold0 Sell0 Strong Sell

Recent Analyst Ratings

Date	Firm	Action	Rating	Previous
2026-03-20	Mizuho	maintain	Outperform	Outperform
2026-01-23	Leerink Partners	upgrade	Outperform	Market Perform
2025-11-19	Mizuho	upgrade	Outperform	Neutral

Forward Estimates

Period	EPS Est.	Revenue Est.	# Analysts
Fri Dec 31	$-0.96	$32.5M	2
Sun Dec 31	$-0.98	$19.0M	3
Mon Dec 31	$-0.70	$88.4M	1
Tue Dec 31	$-0.45	$144.5M	1